The present disclosure pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present disclosure pertains to hemostasis valves and methods for making and using hemostasis valves.
A wide variety of medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. A method for assembling a hemostasis valve is disclosed. The method comprises: positioning a plunger along a threaded proximal end region of a main body; wherein threaded proximal end region of the main body includes one or more threads and an axial slot extending through the one or more threads; advancing the plunger along the threaded proximal end region of the main body to a position where a proximal end of the plunger is disposed distally of at least a portion of the one or more threads; disposing a nut adjacent to the threaded proximal end region of the main body, the nut having an alignment tab formed thereon; aligning the alignment tab with the axial slot; engaging the nut with the one or more threads while the alignment tab is aligned with the axial slot; and rotating the nut 45-270° relative to the threaded proximal end region of the main body.
Alternatively or additionally to any of the embodiments above, further comprising disposing a first seal member within the threaded proximal end region of the main body.
Alternatively or additionally to any of the embodiments above, further comprising disposing a cartridge at least partially within the threaded proximal end region of the main body, the cartridge including a second seal member.
Alternatively or additionally to any of the embodiments above, rotating the nut 45-270° relative to the threaded proximal end region of the main body engages the nut with the cartridge.
Alternatively or additionally to any of the embodiments above, further comprising moving the plunger proximally relative to the threaded proximal end region of the main body.
Alternatively or additionally to any of the embodiments above, further comprising disposing a spring within the plunger.
Alternatively or additionally to any of the embodiments above, further comprising securing a plunger cap to the plunger.
Alternatively or additionally to any of the embodiments above, the threaded proximal end region of the main body has a first locking indicator.
Alternatively or additionally to any of the embodiments above, the plunger includes a second locking indicator and wherein positioning a plunger along a threaded proximal end region of a main body includes aligning the first locking indicator with the second locking indicator.
Alternatively or additionally to any of the embodiments above, rotating the nut 45-270° relative to the threaded proximal end region of the main body includes rotating the nut 90-180° relative to the threaded proximal end region of the main body.
Alternatively or additionally to any of the embodiments above, rotating the nut 45-270° relative to the threaded proximal end region of the main body includes rotating the nut 180° relative to the threaded proximal end region of the main body.
A method for assembling a hemostasis valve is disclosed. The method comprises: advancing a plunger along a threaded proximal end region of a main body; wherein the threaded proximal end region has one or more threads and an axial slot; wherein advancing the plunger along a threaded proximal end region of a main body includes advancing the plunger to a position where a proximal end of the plunger is disposed distally of at least a portion of the one or more threads; engaging a nut with the threaded proximal end region of the main body, the nut having an alignment tab formed thereon; aligning the alignment tab with the axial slot; and rotating the nut 90-180° relative to the threaded proximal end region of the main body.
Alternatively or additionally to any of the embodiments above, further comprising disposing a first seal member within the threaded proximal end region of the main body and further comprising disposing a cartridge at least partially within the threaded proximal end region of the main body, the cartridge including a second seal member.
Alternatively or additionally to any of the embodiments above, rotating the nut 45-270° relative to the threaded proximal end region of the main body engages the nut with the cartridge.
Alternatively or additionally to any of the embodiments above, further comprising moving the plunger proximally relative to the threaded proximal end region of the main body.
Alternatively or additionally to any of the embodiments above, further comprising disposing a spring within the plunger and securing a plunger cap to the plunger.
Alternatively or additionally to any of the embodiments above, the threaded proximal end region of the main body has a first locking indicator, wherein the plunger includes a second locking indicator, and wherein positioning a plunger along a threaded proximal end region of a main body includes aligning the first locking indicator with the second locking indicator.
Alternatively or additionally to any of the embodiments above, rotating the nut 90-180° relative to the threaded proximal end region of the main body includes rotating the nut 180° relative to the threaded proximal end region of the main body.
A method for assembling a hemostasis valve is disclosed. The method comprises: disposing a cartridge at least partially within a threaded proximal end region of a main body; wherein the proximal end region of the main body has an axial slot formed therein; engaging a nut with the threaded proximal end region of the main body, the nut having an alignment slot formed therein; aligning the alignment slot with the axial slot; rotating the nut 90-180° relative to the threaded proximal end region of the main body; and coupling a plunger to the main body.
Alternatively or additionally to any of the embodiments above, rotating the nut 90-180° relative to the threaded proximal end region of the main body includes rotating the nut 180° relative to the threaded proximal end region of the main body.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The disclosure may be more completely understood in consideration of the following detailed description in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about”, whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (e.g., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include one or more particular features, structures, and/or characteristics. However, such recitations do not necessarily mean that all embodiments include the particular features, structures, and/or characteristics. Additionally, when particular features, structures, and/or characteristics are described in connection with one embodiment, it should be understood that such features, structures, and/or characteristics may also be used connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
A number of medical procedures, for example intravascular procedures, utilize medical devices within body lumens. For example, some intravascular procedures include the placement of a guidewire, guide catheter, interventional device, or the like in a blood vessel. Because fluid under pressure (e.g., blood) is present within the blood vessel, fluid could travel along or through the medical device and escape or leak from the patient. In some instances, it may be desirable to dispose a hemostasis valve or hemostasis valve assembly at the proximal end of a medical device to reduce or otherwise limit the leaking of fluids/blood from the proximal end of the device.
An example hemostasis valve 10 is shown in
Other features of the hemostasis valve 10 that can be seen in
As indicated above, the hemostasis valve 10 is designed so that it may be coupled to another device. For example, the adapter 16, which may take the form of a Tuohy-Borst or other type of connector, may be engaged with the proximal end of the other device. When connected (and with the plunger 18 in the configuration shown in
Collectively, when the hemostasis valve 10 is connected to another device and in the configuration shown in
In order to prevent backflow of relatively high pressure fluids, the hemostasis valve 10 can be actuated to close or “seal” the second seal member 26. To do so, the plunger 18 may initially be urged distally until a distally-facing, proximal end surface or cap 42 of the plunger 18 is disposed adjacent to a proximal end region 44 of the nut 28 as shown in
For the purposes of this disclosure, “clockwise” rotation of the plunger 18 and/or nut 28 may be understood as rotation of the plunger 18 in a clockwise direction relative to the main body 12 when looking at the plunger 18 from its proximal end. Similarly, “counter-clockwise” rotation of the plunger 18 and/or nut 28 may be understood as rotation of the plunger 18 in a counter-clockwise direction relative to the main body 12 when looking at the plunger 18 from its proximal end. This convention for clockwise/counter-clockwise is used throughout this disclosure.
The process for assembling the hemostasis valve 10 (and/or other hemostasis valves disclosed herein) is generally designed so that assembly can occur using mechanical fittings (e.g., using only mechanical fitting such that no gluing may be necessary). In addition, the process is designed so that the nut 28 can apply a suitable amount of force onto the cartridge 20 so that the cartridge 20 is seated in the desired manner within the proximal end region 22 of the main body 12 and so that the second seal member 26 remains open. Some additional details of the assembly process are described herein.
The process for assembling the hemostasis valve 110 may include disposing a second seal member (not shown, but may be similar to the second seal member 26 disclosed herein) and a cartridge 120 within the proximal end region 122 of the main body 112. The cartridge 120 may be similar in form to other cartridges disclosed herein and may include a first seal member (e.g., similar to the first seal member 24). In addition, the plunger 118 may be advanced along the proximal end region 122 of the main body 112 as shown in
As shown in
The plunger 118 can be moved proximally as shown in
As also shown in
Other manufacturing methods are contemplated. In at least some of these instances, the plunger 118 may be “pre-assembled”. For example, the plunger cap 156 may be secured to the plunger 118. The spring member 154 may be loaded into the plunger 118 (e.g., over the inner tubular region 158) and the nut 128 may be loaded into the plunger 118. This subassembly may be brought into engagement with the proximal end region 122 of the main body 112. This may include advancing the locking tab 141 through the opening 137 of the ring member 136 and engaging the nut 128 with the threads 130. The locking tab 141 may be positioned along the distal end of the plunger 118 and project radially inward. The plunger 118 can be rotated to engage the nut 128 with the threads 130. While doing so, the locking indicator 159 may be utilized to track the amount of rotation of the plunger 118 (e.g., and/or the nut 128) so that the nut 128 can be threaded onto the threads 130 the desired amount.
The method of assembling the hemostasis valve 210 may include disposing a second seal member (not shown, but may be similar to the second seal member 26) and a cartridge at least partially within the proximal end region 222 of the main body 212. While the entire cartridge is not shown a projection 250 of the cartridge, similar to the projection 150, can be seen in
Once the nut 228 is secured in the desired manner to the proximal end region 222, the plunger 218 may be slid over the nut 228. When doing so, a locking tab 264 may passed through the slot 262 in the nut 228. This may include passing at least a portion of the plunger 218 over or through an opening a ring member 236 disposed along the proximal end region 222 of the main body 212.
It can be appreciated that the assembly process for the hemostasis valve 210, for example because of the slot 262 in the nut 228, allows for a single-piece plunger 218 to be used (as contrasted with the 2-piece plunger 118 shown in
The materials that can be used for the various components of the hemostasis valve 10 (and/or other hemostasis valves disclosed herein) and the various components thereof disclosed herein may include those commonly associated with medical devices. For simplicity purposes, the following discussion makes reference to the main body 12 and other components of the hemostasis valve 10. However, this is not intended to limit the devices and methods described herein, as the discussion may be applied to other hemostasis valves and/or components thereof disclosed herein.
The main body 12 and/or other components of the hemostasis valve 10 may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the sheath can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6 percent LCP.
Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 62/470,659 filed on Mar. 13, 2017, the disclosure of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2023267 | De Saint Rapt et al. | Dec 1935 | A |
2833568 | Corsette | May 1958 | A |
3095175 | Taisho | Jun 1963 | A |
3180334 | Glenn | Apr 1965 | A |
3685786 | Woodson | Aug 1972 | A |
4000739 | Stevens | Jan 1977 | A |
4177814 | Knepshield et al. | Dec 1979 | A |
4240411 | Hosono | Dec 1980 | A |
4424833 | Spector et al. | Jan 1984 | A |
4430081 | Timmermans | Feb 1984 | A |
4436519 | O'Neill | Mar 1984 | A |
4610655 | Mueller | Sep 1986 | A |
4612010 | Hamacher et al. | Sep 1986 | A |
4615531 | Green | Oct 1986 | A |
4626245 | Weinstein | Dec 1986 | A |
4629450 | Suzuki et al. | Dec 1986 | A |
4655752 | Honkanen et al. | Apr 1987 | A |
4673393 | Suzuki et al. | Jun 1987 | A |
4705511 | Kocak | Nov 1987 | A |
4723550 | Bales et al. | Feb 1988 | A |
4726374 | Bales et al. | Feb 1988 | A |
4798594 | Hillstead | Jan 1989 | A |
4857062 | Russell | Aug 1989 | A |
4875062 | Rakov | Oct 1989 | A |
4895346 | Steigerwald | Jan 1990 | A |
4895565 | Hillstead | Jan 1990 | A |
4909798 | Fleischhaker et al. | Mar 1990 | A |
4917668 | Haindl | Apr 1990 | A |
4925450 | Imonti et al. | May 1990 | A |
4932114 | Morse et al. | Jun 1990 | A |
4932633 | Johnson et al. | Jun 1990 | A |
4960412 | Fink | Oct 1990 | A |
4978341 | Niederhauser | Dec 1990 | A |
5000745 | Guest et al. | Mar 1991 | A |
5009391 | Steigerwald | Apr 1991 | A |
5030206 | Lander | Jul 1991 | A |
5041095 | Littrell | Aug 1991 | A |
5049071 | Davis et al. | Sep 1991 | A |
5059186 | Yamamoto et al. | Oct 1991 | A |
5060987 | Miller | Oct 1991 | A |
5078433 | Morse et al. | Jan 1992 | A |
5078688 | Lobodzinksi et al. | Jan 1992 | A |
5098393 | Amplatz et al. | Mar 1992 | A |
5106054 | Mollenauer et al. | Apr 1992 | A |
5114408 | Fleischhaker et al. | May 1992 | A |
5125903 | McLaughlin et al. | Jun 1992 | A |
5135492 | Melker et al. | Aug 1992 | A |
5149327 | Oshiyama | Sep 1992 | A |
5154701 | Cheer et al. | Oct 1992 | A |
5158553 | Berry et al. | Oct 1992 | A |
5161773 | Tower | Nov 1992 | A |
5167636 | Clement | Dec 1992 | A |
5167637 | Okada et al. | Dec 1992 | A |
5176652 | Littrell | Jan 1993 | A |
5195980 | Catlin | Mar 1993 | A |
5197463 | Jeshuran | Mar 1993 | A |
5203774 | Gilson et al. | Apr 1993 | A |
5205831 | Ryan et al. | Apr 1993 | A |
5207656 | Kranys | May 1993 | A |
5224929 | Remiszewski | Jul 1993 | A |
5241990 | Cook | Sep 1993 | A |
5269764 | Vetter et al. | Dec 1993 | A |
5269771 | Thomas et al. | Dec 1993 | A |
5273546 | Mclaughlin et al. | Dec 1993 | A |
5282790 | Clement | Feb 1994 | A |
5299843 | Weigl et al. | Apr 1994 | A |
5324271 | Abiuso et al. | Jun 1994 | A |
5338313 | Mollenauer et al. | Aug 1994 | A |
5350205 | Aldridge et al. | Sep 1994 | A |
5350364 | Stephens et al. | Sep 1994 | A |
5352215 | Thome et al. | Oct 1994 | A |
5356394 | Farley et al. | Oct 1994 | A |
5364371 | Kamen | Nov 1994 | A |
5376077 | Gomringer | Dec 1994 | A |
5382230 | Bonn | Jan 1995 | A |
5383860 | Lau | Jan 1995 | A |
5389090 | Fischell et al. | Feb 1995 | A |
5395349 | Quiachon et al. | Mar 1995 | A |
5460615 | Storz | Oct 1995 | A |
5514109 | Mollenauer et al. | May 1996 | A |
5520655 | Davila et al. | May 1996 | A |
5542933 | Marks | Aug 1996 | A |
5562611 | Transue | Oct 1996 | A |
5569208 | Woelpper et al. | Oct 1996 | A |
5575767 | Stevens | Nov 1996 | A |
5584314 | Bron | Dec 1996 | A |
5591137 | Stevens | Jan 1997 | A |
5599327 | Sugahara et al. | Feb 1997 | A |
5643227 | Stevens | Jul 1997 | A |
5651170 | Stevens | Jul 1997 | A |
5693025 | Stevens | Dec 1997 | A |
5779697 | Glowa et al. | Jul 1998 | A |
5858007 | Fagan et al. | Jan 1999 | A |
5911710 | Barry et al. | Jun 1999 | A |
5921968 | Lampropoulos et al. | Jul 1999 | A |
5935112 | Stevens et al. | Aug 1999 | A |
5935122 | Fourkas et al. | Aug 1999 | A |
5992899 | Strowe | Nov 1999 | A |
6024729 | Dehdashtian et al. | Feb 2000 | A |
6149632 | Landuyt | Nov 2000 | A |
6277100 | Raulerson et al. | Aug 2001 | B1 |
6287280 | Lampropoulos et al. | Sep 2001 | B1 |
6331176 | Becker et al. | Dec 2001 | B1 |
6402723 | Lampropoulos et al. | Jun 2002 | B1 |
6458103 | Albert et al. | Oct 2002 | B1 |
6551283 | Guo et al. | Apr 2003 | B1 |
6572590 | Stevens et al. | Jun 2003 | B1 |
6632200 | Guo et al. | Oct 2003 | B2 |
6695818 | Wollschlger | Feb 2004 | B2 |
6986749 | Wollschlger | Jan 2006 | B2 |
7081106 | Guo et al. | Jul 2006 | B1 |
7172580 | Hruska et al. | Feb 2007 | B2 |
7938809 | Lampropoulos et al. | May 2011 | B2 |
8777893 | Malewicz | Jul 2014 | B2 |
9114242 | Fangrow | Aug 2015 | B2 |
9592372 | Myers | Mar 2017 | B2 |
20010021825 | Becker et al. | Sep 2001 | A1 |
20020010425 | Guo et al. | Jan 2002 | A1 |
20040172008 | Layer | Sep 2004 | A1 |
20040210194 | Bonnette et al. | Oct 2004 | A1 |
20050033239 | Argentine | Feb 2005 | A1 |
20050171479 | Hruska et al. | Aug 2005 | A1 |
20070106262 | Becker et al. | May 2007 | A1 |
20080157017 | Macatangay et al. | Jul 2008 | A1 |
20080208175 | Beckman et al. | Aug 2008 | A1 |
20090259200 | Lampropoulos et al. | Oct 2009 | A1 |
20120123392 | McKinnon | May 2012 | A1 |
20130006176 | Miller | Jan 2013 | A1 |
20130304026 | Luther | Nov 2013 | A1 |
20140207083 | Pessin | Jul 2014 | A1 |
20180126143 | Agrawal et al. | May 2018 | A1 |
Number | Date | Country |
---|---|---|
29701600 | Jul 1997 | DE |
0567142 | Oct 1993 | EP |
9813083 | Apr 1998 | WO |
9945983 | Sep 1999 | WO |
0062844 | Oct 2000 | WO |
0117587 | Mar 2001 | WO |
2005018732 | Mar 2005 | WO |
2009139981 | Nov 2009 | WO |
Entry |
---|
PCT Search Report and Written Opinion for PCT/US2009/039396 dated Apr. 3, 2009. |
International Search Report and Written Opinion dated Jun. 20, 2018 for International Application No. PCT/US2018/019712. |
International Search Report and Written Opinion for Application No. PCT/US2018/020202, 14 pages, dated May 25, 2018. |
International Search Report and Written Opinion for Application No. PCT/US2018/020214, 17 pages, dated May 15, 2018. |
International Search Report and Written Opinion for Application No. PCT/US2018/019674, 13 pages, dated Jun. 13, 2018. |
International Search Report and Written Opinion for Application No. PCT/US2018/019479, 13 pages, dated May 22, 2018. |
Number | Date | Country | |
---|---|---|---|
20180256871 A1 | Sep 2018 | US |
Number | Date | Country | |
---|---|---|---|
62470659 | Mar 2017 | US |